Phase 2 Study of KH001 in Long-term Relief from Dentin Hypersensitivity

Launched by HYSENSBIO CO., LTD · Jun 13, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment called KH001 to help people who suffer from dentin hypersensitivity, which is a condition that causes sharp pain in the teeth, often triggered by hot or cold foods and drinks. The goal of this study is to see how effective and safe KH001 is for providing long-term relief from this discomfort.

To participate in the trial, individuals must be at least 18 years old and in good overall health. They should have at least two teeth that are sensitive, meaning they feel pain when exposed to certain stimuli. However, people with allergies to the treatment or those who have recently received similar treatments will not be eligible to join. If someone decides to participate, they can expect to be monitored closely by healthcare professionals throughout the study to ensure their safety and to assess how well the treatment works.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Is at least 18 years old by the time of the screening visit
• • Is in good general health as determined by the investigator
• • Has at least 2 non-adjacent teeth and is diagnosed with hypersensitive
• Exclusion Criteria:
• • Is allergic to the active drug substance or other excipients used in the investigational product
• • Has any history of alcohol or drug abuse
• • Has received any treatment related to dentin hypersensitivity within 8 weeks prior to the screening visit
• • Is jedged by the investigator as ineligible for participation for other reasons